The tafazzin gene encodes a phospholipid-lysophospholipid transacylase involved in cardiolipin metabolism, but it is not known why it forms multiple transcripts as a result of alternative splicing. Here we studied the intracellular localization, enzymatic activity, and metabolic function of four isoforms of human tafazzin and three isoforms of Drosophila tafazzin upon expression in different mammalian and insect systems. When expressed in HeLa cells, all isoforms were localized in mitochondria except for the B-form of Drosophila tafazzin, which was associated with multiple intracellular membranes. Among the human isoforms, only full-length tafazzin (FL) and tafazzin lacking exon 5 (⌬5) had transacylase activity, and only these two isoforms were able to restore a normal cardiolipin pattern, normal respiratory activity of mitochondria, and male fertility in tafazzin-deficient flies. Both FL and ⌬5 were associated with large protein complexes in 293T cell mitochondria, but treatment with alkali and proteinase K suggested that the ⌬5 isoform was more integrated into the hydrophobic core of the membrane than the FL isoform. Although all Drosophila isoforms showed transacylase activity in vitro, only the A-form supported cardiolipin remodeling in flies. The data suggest that humans express two mitochondrial isoenzymes of tafazzin that have similar transacylase activities but different membrane topologies. Furthermore, the data show that the expression of human tafazzin in flies creates cardiolipin with a Drosophila pattern, suggesting that the characteristic fatty acid profile of cardiolipin is not determined by the substrate specificity of tafazzin.
Alternative mRNA splicing can potentially increase the number of proteins expressed by a single gene and may thus raise the complexity of the translated information. Although alternative splicing is common among human genes, evidence for the presence of multiple functionally active splice products has rarely been presented (1). Tafazzin is one example in which alternative splicing could, in theory, lead to a number of related proteins and where reasons for such diversification may exist.
Tafazzin is a phospholipid-lysophospholipid transacylase (2) that is involved in the generation of the characteristic fatty acid profile 3 of mitochondrial cardiolipin (CL) 4 (3, 4) and that is mutated in patients with Barth syndrome (5), a human disease presenting with cardiomyopathy, skeletal muscle weakness, episodic neutropenia, growth disturbances, and abnormal mitochondria (6 -8) . The initial study of the human tafazzin gene suggested that it produces 10 different mRNAs as a result of alternative initiation and splicing (5) , but only four were confirmed by later studies (9, 10) . Sequence alignment analysis demonstrated that hTAZ-⌬5, the splice variant that skips the fifth exon, shows the highest degree of homology to tafazzins from other organisms and thus likely represents the principal isoform (11) . This idea was supported by the fact that hTAZ-⌬5 forms the dominant band in reverse transcription-PCR (9, 10) and that it is the only species that can rescue CL deficiency in a tafazzin mutant of yeast (11) . Other isoforms of human tafazzin include hTAZ-FL (full-length), hTAZ-⌬7 (skips seventh exon), and hTAZ-⌬5⌬7 (skips fifth and seventh exons); i.e. in comparison with the principal isoform, the modifications include (i) the insertion of an additional 31-residue peptide (hTAZ-FL), (ii) the deletion of exon 7 (hTAZ-⌬5⌬7), and (iii) the two modifications combined (hTAZ-⌬7) (Fig. 1) .
The presence of four tafazzin transcripts raises the question whether structural modifications of tafazzin may cause variations in its targeting or its substrate specificity, both of which could have significant functional implications. The question whether tafazzin may have various functions is the more relevant as multiple tafazzin transcripts exist not only in humans but also in Drosophila, where the isoforms dTAZ-A, dTAZ-B, and dTAZ-C vary by the length of the N-terminal sequence preceding the hydrophobic anchor region (Fig. 1) . In this study, we investigated the intracellular localization and enzymatic function of tafazzin isoforms from humans and Drosophila, and we studied their phenotypic effect upon transgenic expression in tafazzin-deficient flies. The purpose of the study was to elucidate the function of alternative splicing in tafazzin expression.
EXPERIMENTAL PROCEDURES
Fly Strains-Tafazzin-deficient mutant flies (⌬TAZ) were created as described (12) . Transgenic fly strains containing UAS-controlled transgenes dTAZ-A, dTAZ-B, dTAZ-C, hTAZ-FL, hTAZ-⌬5, hTAZ-⌬7, and hTAZ-⌬5⌬7, respectively, were generated by recombination-mediated cassette exchange, which inserts transgenes into precise genomic "landing sites," thus eliminating potential "position effects" from nearby endogenous regulatory elements and making precise comparisons between multiple constructs possible (13) . Briefly, cDNAs encoding various tafazzin isoforms were subcloned individually into the multiple cloning site of the donor plasmid vector pBS-loxP-w-UAST-lox2272 (a gift from Dr. Hyung Don Ryoo, New York University School of Medicine), which was modified from pBS-loxP-w-lox2272 (13) by inserting into the unique BamHI site a UAS-MCS-SV40 cassette (BamHI fragment) of pUAST (14) . The donor plasmids were then injected along with the Cre recombinase helper plasmid into early embryos homozygous for the landing site loxP-y-lox2272 on the third chromosome at 3L:68A. Surviving flies were crossed to y Ϫ w Ϫ flies, and offspring were screened for exchange events by scoring for the loss of body pigment (y Ϫ ) and the gain of eye pigment (w ϩ ). For transgenic rescue of the tafazzin mutant phenotype, both UAS-tafazzin transgenic lines and the third chromosome daughterless-GAL4 driver line were further crossed into the tafazzin mutant background, respectively, by using standard Drosophila genetic techniques and appropriate fly strains. Male fertility was assessed by placing five males with five virgin w 1118 females in a culture vial for 6 days at 20°C, followed by counting the F 1 progeny. At least three vials were set up and scored for each genotype tested. Climbing activity was measured as described (12) . To isolate total fly membranes, 100 flies were Dounce-homogenized in 1 ml of ice-cold phosphate-buffered saline containing a protease inhibitor mixture. The total fly homogenate was centrifuged at 750 ϫ g for 5 min at 4°C to remove large debris; the supernatant was then sonicated (15 s) , and the total membrane fraction was obtained by centrifugation at 100,000 ϫ g for 60 min.
Fly Mitochondria-Fly mitochondria were isolated by differential centrifugation as described previously (2) . Their respiratory activity was measured with the BD Oxygen Biosensor System (BD Biosciences) according to the specifications of the manufacturer. The medium contained 250 mM sucrose, 15 mM KCl, 1 mM EGTA, 5 mM MgCl 2 , 30 mM KH 2 PO 4 , 7 mM succinate, 2 mM ADP, and 1.5 mg/ml mitochondrial protein (pH 7.4).
Expression of Tafazzins in HeLa Cells-The cDNAs encoding various tafazzin isoforms were subcloned individually into mammalian expression vector pcDNA3 (Invitrogen), downstream of a hemagglutinin epitope (HA) tag. HeLa cells were transfected with the pcDNA3 plasmids containing various tafazzin cDNAs using FuGENE 6 transfection reagent (Roche Applied Science). Forty h after transfection, cells were harvested and broken by sonication, and sedimentable membrane and cytosolic supernatant fractions were obtained by centrifugation (60 min at 100,000 ϫ g).
Expression of Tafazzins in Recombinant Baculovirus Sf9 Insect Cell Expression System-Sf9 insect cells were cultured at 27°C in TNM-FH insect medium (BD Biosciences) and passaged every 3 days. cDNAs of tafazzin isoforms (TAZ) were subcloned individually in NcoI-KpnI sites of the baculovirus shuttle vector pAc-XL, which we modified from pAc-GHLT-C DNA (BD Biosciences) by eliminating the glutathione S-transferase (GST) tag. Using calcium precipitation, 5 g of pAc-XL-TAZ DNA and 0.5 g of BD BaculoGold TM linearized baculovirus DNA (BD Biosciences) were co-transfected with 2 million Sf9 cells cultured in TNM-FH medium. Transfected cells were kept at 27°C for 4 h, after which the transfection medium was removed and replaced by fresh TNM-FH medium. Amplification of recombinant TAZ baculoviruses in Sf9 cells was carried out to increase the virus titer. Recombinant baculovirus released into the cell medium was harvested and kept at 4°C as stock solution. For the expression experiments, Sf9 cells were infected with the TAZ baculovirus stocks and then cultured at 27°C for 3-4 days. For the isolation of subcellular membranes, cells were harvested and homogenized with a tight-fitting Teflon glass homogenizer in isolation buffer containing 210 mM mannitol, 70 mM sucrose, 1 mM EGTA, and 5 mM Hepes (pH 7.2) at 4°C. Cell debris and nuclei were removed by centrifugation at 750 ϫ g for 5 min. Mitochondria were collected from the supernatant by centrifugation at 17,000 ϫ g for 20 min. Microsomes were collected from the post-mitochondrial supernatant by centrifugation at 100,000 ϫ g for 60 min. Protein concentrations of the subcellular fractions were determined by the method of Lowry (15) .
Expression of Tafazzins in 293T Cells-293 T cells were grown to 60% confluency in T-75 flasks and transfected with pcDNA3 vector encoding HA-tagged hTAZ-⌬5 or hTAZ-FL. Briefly, 24 l of FuGENE transfection reagent was added to 776 l of serum-free Dulbecco's modified Eagle's medium in an autoclaved Eppendorf tube. After incubation for 5 min, 8 g of the appropriate vector DNA was added, and the tubes were incubated for 30 min with occasional mixing. Subsequently, the mixture was added to the T-75 flasks and incubated for 2 days at 37°C and 5% CO 2 . Mitochondria were isolated from 293 T cells following the method of Magalhaes et al. (16) . Briefly, cells were collected and swollen in hypotonic buffer (10 mM Tris, 10 mM NaCl, 1.5 mM MgCl 2 (pH 7.4) at 4°C) on ice for 15 min. Subsequently, they were homogenized on ice by 30 upand-down strokes in a Teflon-glass homogenizer. Immediately, the tonicity was restored by the addition of an aliquot of 2 M sucrose. Nuclei and debris were removed by centrifugation at 1,500 ϫ g for 10 min, and mitochondria were collected from the supernatant by centrifugation at 17,000 ϫ g for 10 min. Mitochondria were stored in aliquots at Ϫ80°C.
Confocal Immunofluorescence Microscopy-HeLa cells expressing HA-tagged tafazzin were grown on coverslips and then incubated for 30 min with medium containing MitoTracker CMXROS Red (GE Healthcare). Cells were washed twice with phosphate-buffered saline (PBS) and then fixed with 4% paraformaldehyde in PBS for 30 min at room temperature. Subsequently, cells were washed again with PBS, and free aldehyde groups were quenched with 0.05 M NH 4 Cl in PBS for 10 min. Cells were permeabilized and blocked by incubation for 30 min with 0.02% Triton-X100 in PBS containing 2% bovine serum albumin. Primary mouse anti-HA monoclonal antibodies, diluted 1:1000 in the blocking buffer (2% bovine serum albumin in PBS), were added to the cells and incubated for 2 h at room temperature. After several washes with the blocking buffer, the cells were incubated for 90 min at room temperature with fluorescein isothiocyanateconjugated donkey anti-mouse IgG diluted 1:200 in the blocking buffer. The coverslips were washed with the blocking buffer, mounted in Prolong Gold Anti-fade reagent (Molecular Probes), and examined with a Zeiss confocal microscope. For double labeling with the endoplasmic reticulum marker calnexin or the Golgi marker giantin, cells expressing HA-tagged tafazzin were fixed directly without incubation with MitoTracker and then processed similarly to the manner described above, except that the cells were incubated with two primary antibodies (mouse anti-HA together with rabbit anticalnexin or goat anti-giantin) and two secondary antibodies (Texas Red-conjugated donkey anti-mouse IgG together with fluorescein isothiocyanate-conjugated donkey anti-rabbit IgG and fluorescein isothiocyanate-conjugated donkey anti-goat IgG).
Protease and Alkali Treatments of Mitochondria-Limited protease digestion of mitochondria (50 g protein/sample, protein concentration 0.5 mg/ml) was performed in the presence of proteinase K at a final concentration of 20 or 200 ng/ml (protein-to-proteinase K ratio of 25,000:1 or 2,500:1) in the absence or presence of detergents (digitonin 1 g/g protein or 0.1% Triton X-100). The digestion was carried out on ice for 30 min and stopped by the addition of 4 mM phenylmethylsulfonyl fluoride. Samples were immediately boiled in SDS-PAGE loading buffer for 10 min. Alkali treatment of mitochondria (50 g protein/ sample) was carried out in 0.1 M NaHCO 3 buffer (pH 10 -12.5) on ice for 20 min. The treated mitochondria were immediately centrifuged to separate released proteins from bound proteins.
BN-PAGE Analysis of Tafazzins in 293T Cell
Mitochondria-BN-PAGE analysis was carried out as described by Wittig et al. (17) with minor modifications. Mitochondria from 293T cells (800 g of protein) were solubilized in digitonin (8 g/g protein) for 9 min at room temperature under constant stirring. Solubilized proteins were collected in the supernatant after ultracentrifugation for 15 min at 100,000 ϫ g. Five l of 50% glycerol and 12 l of 5% Coomassie Blue G-250 were added to 60 l of supernatant, and the mixture was loaded on a 4 -13% gradient polyacrylamide gel and subjected to electrophoresis at 96 V for 3 h. Following the run, the gel was stained with Coomassie Blue G-250 for 10 min and then destained in water for 1 day. For Western blotting, proteins were electrotransferred from the gel to a methanol-soaked PVDF membrane for 3 h at 30 V in Tricine buffer (50 mM Tricine, 7.5 mM imidazole, pH 7.0). The PVDF membrane was further fixed and destained by a 10-min wash in water-methanol-glacial acetic acid (85-10-5) followed by a 10-min wash in 1% SDS in 50 mM Tris (pH 6.8), then two 3-min rinses in 75% methanol, and finally a 1-min rinse in 100% methanol. Then, the PVDF was incubated in TBST buffer (0.88% NaCl, 0.02% KCl, 0.3% Tris, 0.05% Tween 20, pH 7.4) overnight. The following day, regular immunoblotting was performed using primary HA mouse-monoclonal antibody (1:1,000) and secondary antibody conjugated with horseradish peroxidase (1:2,000).
Western Blotting-For Western blot analysis of tafazzins, samples were denatured by boiling in SDS loading buffer and then applied to 10% gels for SDS-PAGE. Protein bands were transferred onto nitrocellulose membranes in a solution containing 20% methanol in Tris-glycine-SDS (Bio-Rad). After blocking, the blots were incubated overnight at 4°C either with 1 g/ml affinity-purified rabbit polyclonal antibodies raised against Drosophila tafazzin (12) or with 1 g/ml affinity-purified chicken polyclonal immunoglobulin Y raised against human tafazzin. The hTAZ antibody was purified by the same technique as employed previously for the dTAZ antibody (12) . Incubation with primary antibodies was followed by incubation with horseradish peroxidase-conjugated secondary antibodies for 2 h at room temperature. SuperSignal (Pierce) was used as the peroxidase substrate. For Western blot analysis of HA tag, respiratory complex I, and voltage-dependent anion channel (VDAC), all primary antibodies were utilized in a concentration of 1 g/ml in 5% nonfat milk-TBST and incubated for 2 h at room temperature. HA antibody was purchased from Sigma, and monoclonal antibodies to mitochondrial membrane mark- ]oleoyl-2-lyso-phosphatidic acid (1 Ci). The reactions were started by the addition of Sf9 mitochondria (10 g of protein for PC/lyso-PC assay and 80 g of protein for all other assays), and they were stopped after 5 min by the addition of 2 ml of methanol and 1 ml of chloroform. Phospholipids were extracted (18) and separated by thin-layer chromatography on silica gel 60 (Merck) with chloroform/ methanol/water (65-25-4, v/v/v). For the PC/monolyso-CL combination, reaction products were separated by two-dimensional thin-layer chromatography using chloroformmethanol-water (65-25-4, v/v/v) in the first dimension and chloroform-acetone-methanol-acetic acidwater (50-20-10-10-5 by vol.) in the second dimension. Tracer lipids were included before thin-layer chromatography.
Phospholipids were visualized by brief exposure to iodine and marked. Subsequently, iodine was removed by evaporation, and the lipid spots were scraped off for measurement of radioactivity by liquid scintillation counting.
Fatty Acid Analysis-For the analysis of fatty acid patterns, lipids were extracted from Sf9 cell pellets (18) and separated by two-dimensional thin-layer chromatography on silica gel 60 using chloroform/ methanol/20% ammonia (65-30-5, v/v/v) in the first dimension and chloroform/acetone/methanol/acetic acid/water (50-20-10-10-5 by vol.) in the second dimension. Lipids were visualized by brief exposure to iodine. Silica spots corresponding to CL, PC, and phosphatidylethanolamine were scraped into long-neck glass vials and transmethylated overnight in methanol/0.5 M HCl at 90°C. Then, the reaction mixtures were neutralized, and fatty acid methyl esters were extracted into n-hexane. Samples were concentrated by evaporation of solvent and then analyzed by capillary gas chromatography using a Shimadzu GC-17A gas chromatograph equipped with an SP-2330 column (0.32 mm ϫ 30 m, 0.2-m column film) and a flame ionization detector. Fatty acid methyl esters were separated isothermically at 185°C.
Cardiolipin Analysis by MALDI-TOF Mass SpectrometryMitochondria were isolated from fly strains, and lipids were extracted (18) and supplemented with 6 nmol of internal standard ((14:0) 4 -CL)/mg of protein. Aliquots of the lipid extracts, corresponding to 0.5 mg of mitochondrial protein, were dried and redissolved in 50 l of chloroform/methanol (1:1, v/v). Mass spectrometry was performed according to Sun et al. (19) with minor modifications. An aliquot of 5 l of the lipid extract was mixed with 50 l of matrix solution (10 g/liter 9-aminoacridine in 2-propanol/acetonitrile, 6:4, v/v). A 1-l aliquot of this mixture was spotted on the sample plate in a draft-free environ-ment. The matrix solution was cooled to Ϫ20°C to increase viscosity, which prevented migration of the droplets on the plate. MALDI-TOF mass spectrometry was performed with a Bruker Autoflex I instrument equipped with a nitrogen laser and operated in reflectron mode. A minimum of 400 laser shots (8 cycles of 50 shots each) were averaged per spectrum. Spectra were read and analyzed with the software MOVERZ (Proteometrics Inc.). Molecular species were quantified from peak integrals after correction for type I and type II 13 C isotope effects (20) .
Statistics-Bar graphs show the means of triplicate measurements with S.E. For climbing assays, two independent populations of 30 -50 flies were analyzed for each group.
RESULTS

Intracellular Localization of Tafazzin Isoforms-Previous
experiments had suggested that tafazzin is localized in mitochondria (21, 22) . To determine the effect of alternative splicing on intracellular targeting, we expressed HA-tagged constructs of the four isoforms of human tafazzin in HeLa cells. Western blot analysis with HA antibodies confirmed that the constructs produced membrane-bound proteins of the expected size (supplemental Fig. S1 ), and confocal analysis demonstrated that all four human tafazzins were localized in mitochondria (Fig. 2) . Similar experiments with Drosophila tafazzins showed that only dTAZ-A and dTAZ-C were unequivocally localized in mitochondria (Fig. 2) , whereas dTAZ-B displayed a more complex intracellular distribution, co-localizing with markers of mitochondria (Fig. 3A) , the endoplasmic reticulum (Fig. 3B) , and the Golgi apparatus (Fig. 3C) . A polyclonal antibody raised against Drosophila tafazzin detected two bands in immunoblot of total fly membranes (Fig. 3D) , one of which was assigned to dTAZ-A, the dominant isoform, and the other one to dTAZ-B because it co-migrated with the corresponding band in transgenic dTAZ-B-overexpressing flies (not shown). Thus, two out of three tafazzin isoforms were present in sufficient amounts to be detectable by Western blot in Drosophila membranes. Consistent with reverse transcription-PCR data (12), only dTAZ-A was deleted from ⌬TAZ flies (Fig. 3D) . Unfortunately, endogenous levels of tafazzins were not detectable in human tissues with the currently available antibodies. In conclusion, the data demonstrate that all tafazzin isoforms from humans and Drosophila are expressed in mitochondria except for dTAZ-B, which is associated with multiple intracellular compartments.
Transacylase Activity of Tafazzin Isoforms-Next, we determined the effect of alternative splicing on the enzymatic activity of tafazzin. First, we expressed tafazzin isoforms fused to maltose-binding protein in Escherichia coli, affinity-purified the recombinant proteins, and assayed their transacylase activity. Although this strategy worked for dTAZ-A (2), none of the other isoforms of hTAZ and dTAZ were active (data not shown). As an alternative approach, we expressed different dTAZ and hTAZ isoforms in Sf9 insect cells and confirmed their presence by Western blot analysis (supplemental Fig. S2 ). Expression of any of the dTAZ isoforms was associated with a large increase in transacylase activity in Sf9 mitochondria (Fig.  4, A and B) , and all dTAZ isoforms showed the same profile of apparent acyl specificity (Fig. 4C) . Among the hTAZ isoforms, only the expression of hTAZ-⌬5 and hTAZ-FL produced a measurable increase in transacylase activity, whereas hTAZ-⌬5⌬7 and hTAZ-⌬7 were inactive (Fig. 4, D and E) . However, the activities of the hTAZ isoforms were much lower than those of the dTAZ isoforms, and specifically hTAZ-FL showed activity only when measured with the substrate pair phosphatidylglycerol/lyso-[ 3 H]phosphatidic acid (Fig. 4D) . The failure of hTAZ-⌬5⌬7 and hTAZ-⌬7 to increase transacylase activity could not be attributed to low expression levels because their abundance in Western blots was similar or slightly higher than that of hTAZ-⌬5 and hTAZ-FL (supplemental Fig. S2 ).
To verify these results, we determined the effect of hTAZ isoforms on the fatty acid composition of endogenous Sf9 phospholipids. Both hTAZ-⌬5 and hTAZ-FL induced drastic changes in the fatty acid pattern of Sf9 CL, but hTAZ-⌬5⌬7 and hTAZ-⌬7 had no effect (Table 1 ). The changes in the CL profile included an increase of oleic acid at the expense of palmitoleic acid, which was accompanied by small reciprocal changes in the fatty acid pattern of PC but not of phosphatidylethanolamine. Interestingly, expression of hTAZ-⌬5 and hTAZ-FL induced changes in the fatty acid patterns of CL and PC similar to the expression of dTAZ-A (Table 1 ). In conclusion, our data demonstrate that hTAZ-⌬5, hTAZ-FL, dTAZ-A, dTAZ-B, and dTAZ-C are transacylases, whereas hTAZ-⌬5⌬7 and hTAZ-⌬7 are not.
Transgenic Expression of Tafazzin Isoforms in
DrosophilaNext, we tested the ability of the isoforms to rescue the phenotype of a tafazzin mutant of Drosophila (⌬TAZ) in which dTAZ-A was deleted (12) . Specifically, we performed transgenic expression of tafazzin isoforms in ⌬TAZ and measured the effect on motor function (12) , male fertility (23), mitochondrial respiration, and CL deficiency (12) . Climbing assays showed that only dTAZ-A and hTAZ-FL were able to fully restore muscle activity of the mutant. dTAZ-B, dTAZ-C, hTAZ-⌬5, and hTAZ-⌬5⌬7 were partially active, but hTAZ-⌬7 was inactive (Fig. 5) . Fertility measurements revealed that only the isoforms hTAZ-⌬5, hTAZ-FL, and dTAZ-A were able to reverse completely the male sterility associated with the ⌬TAZ FIGURE 5. Transgenic expression of tafazzin isoforms in ⌬TAZ Drosophila. Imprecise excision of the P-element from fly strain KG02529 created flies with deletion of dTAZ-A (⌬TAZ) (12) . Then, various isoforms of tafazzin were expressed in the ⌬TAZ mutant (⌬TAZ ϩ insert). The graphs show the motor function of various transgenic fly strains measured by climbing assay. In this assay, a fly population is distributed between seven tubes according to its climbing activity. Flies in tube 1 have the lowest climbing activity, and flies in tube 7 have the highest climbing activity. FIGURE 6. Phenotype of transgenic fly strains. The P-element was excised from fly strain KG02529, creating either wild-type flies (WT, precise excision of P element) or flies with deletion of dTAZ-A (⌬TAZ, imprecise excision of P element) (12) . Then, various isoforms of tafazzin were expressed in the ⌬TAZ mutant (⌬TAZ ϩ insert). A, male fertility was quantified and expressed as percent of wild-type fertility. B, respiratory activity of isolated mitochondria was measured in the presence of ADP and succinate and expressed as percent of wild-type activity. C, CL was analyzed by MALDI-TOF mass spectrometry, and the amount of (16:1) 2 (18:2) 2 -CL was quantified with the internal standard (14:0) 4 -CL after correcting for 13 C isotope effects (20) . D, the ratio of 68:4-CL (m/z ϭ 1400) over 68:6-CL (m/z ϭ 1396) was determined from MALDI-TOF mass spectra after correction for the type II 13 C isotope effect (20) .
phenotype (Fig. 6A) . The determination of succinate-driven mitochondrial respiration showed that tafazzin deficiency resulted in about 50% reduction of state 3 respiration, which was fully restored only by dTAZ-A, hTAZ-⌬5, and hTAZ-FL (Fig. 6B) . Finally, the effect on CL was analyzed by MALDI-TOF mass spectrometry using a novel method developed by Sun et al. (19) (for complete CL spectra with internal standard, see supplemental Fig. S3 ). First, we confirmed our previous result (12) that the most abundant product of CL remodeling, (16: 1) 2 (18:2) 2 -CL, was reduced by more than 80% in ⌬TAZ flies (Fig. 6C ). This effect was reversed by expression of hTAZ-⌬5, hTAZ-FL, and dTAZ-A but not by expression of any of the other isoforms (Fig. 6C) . The same conclusion was reached by visual inspection of the mass spectra. For instance, the intensity pattern of the C 68 -CL cluster changed upon tafazzin deletion and was converted back to normal only by expression of hTAZ-⌬5, hTAZ-FL, and dTAZ-A (Fig. 7) . The isoforms dTAZ-B and dTAZ-C also had some effect on the C 68 cluster pattern, but hTAZ-⌬5⌬7 and hTAZ-⌬7 were completely inactive (Figs. 7  and 6D ). In conclusion, our data demonstrate that hTAZ-⌬5, hTAZ-FL, and dTAZ-A, but none of the other isoforms, can remodel CL in vivo and restore most of the physiologic defects associated with tafazzin deficiency in Drosophila.
Association of hTAZ-⌬5 and hTAZ-FL with Protein Complexes in Mitochondrial
Membranes-To further characterize the two active isoforms of human tafazzin, we expressed HAtagged constructs of hTAZ-⌬5 and hTAZ-FL in 293T cells, iso- lated the mitochondria, solubilized them with digitonin, and separated the solubilized proteins by BN-PAGE. This method produced a good resolution of protein complexes in the mass range of 100 to 1,000 kDa, and Coomassie-stained protein bands were tentatively assigned to respiratory complexes III, IV, and V according to their molecular mass (Fig. 8A) . Western blot analysis with HA antibody showed that most of hTAZ-⌬5 and most of hTAZ-FL migrated with an apparent mass of about 400 kDa, but only a small portion of the isoforms migrated like monomeric tafazzin (Ͻ100 kDa) (Fig. 8B) . In two of five experiments, the high mass tafazzin was split into at least three distinct bands within the range of 200 to 1,000 kDa (Fig. 8C) . The data are consistent with previous experiments in yeast showing that tafazzin is associated with large protein complexes (24, 25 ), but they demonstrate that the proportion of high mass tafazzin is much higher in our mammalian expression system and that there is no difference in complex association between hTAZ-⌬5 and hTAZ-FL. However, hTAZ-FL was released from mitochondrial membranes by alkali treatment more readily than hTAZ-⌬5, indicating that the former is less integrated into the membrane than the latter (Fig. 8D) . Furthermore, hTAZ-FL was more susceptible to proteinase K treatment than hTAZ-⌬5, although both isoforms had similar submitochondrial localization (Fig. 9 ). This conclusion was reached by comparison with marker enzymes of the outer (VDAC) and inner (complex I) mitochondrial membranes. Whereas digestion of VDAC required the presence of digitonin, digestion of the subunit NDUS3 of complex I was accomplished only in the presence of Triton X-100 (Fig. 9) . Both tafazzin isoforms became more accessible to proteinase K after the addition of digitonin, but complete digestion required Triton X-100. These data are consistent with a previous report in yeast showing that tafazzin is bound to the outer and the inner membrane (24) , but they also show that hTAZ-FL is more susceptible to proteinase K than hTAZ-⌬5, probably because it is less integrated into the membrane. In conclusion, our data demonstrate that both hTAZ-⌬5 and hTAZ-FL are associated with large protein complexes, but hTAZ-⌬5 is more integrated into the hydrophobic core of the membrane than hTAZ-FL.
DISCUSSION
We have characterized the localization and function of four splice variants of human tafazzin and three splice variants of Drosophila tafazzin and found that of these isoforms, only hTAZ-⌬5, hTAZ-FL, and dTAZ-A carry all of the following activities: phospholipid-lysophospholipid transacylation in vitro; CL remodeling in flies and Sf9 insect cells; and support of various physiologic activities such as mitochondrial respiration, male fertility, and flight muscle function in Drosophila ( Table 2 ). The data suggest that humans express two functional isoenzymes of tafazzin and that exon 7 of human tafazzin is essential for catalysis.
What Determines the Intracellular Localization of Tafazzin?-Our localization studies showed that neither exon 7 nor exon 5 of human tafazzin is involved in mitochondrial targeting. Instead, targeting is more likely conferred by the N-terminal portion of tafazzin, at least in Drosophila. This was suggested by the effect that splicing of the N terminus of Drosophila tafazzin has on the intracellular localization of dTAZ-B. Furthermore, the observation that dTAZ-B and dTAZ-C only partially restore the Drosophila phenotype (Table 2) is likely a consequence of their specific intracellular and intramitochondrial localization, because both isoforms have full transacylase activity in vitro. Thus, the N-terminal variations between the three Drosophila isoforms do not have measurable effects on enzymatic function, but they do seem to affect intracellular targeting.
What Is Different between the Two Active Isoenzymes of Human Tafazzin?-The two active isoenzymes of human tafazzin, hTAZ-⌬5 and hTAZ-FL, were largely indistinguishable in terms of their physiologic activities when expressed in Drosophila. In addition, both isoenzymes localized to mitochondria in HeLa cells, and they were associated with large mitochondrial protein complexes in 293T cells. Association of tafazzin with mitochondrial protein complexes, specifically with the ADP-ATP carrier and the ATP synthase, has been shown in yeast, but the proportion of complex-bound tafazzin is small (24, 25) . In contrast, the vast majority of tafazzin was complexassociated in 293T cells, which could be because of the specific cell type but could also be an artifact of the expression system. Our experiments in wild-type Drosophila revealed that most of tafazzin is associated with large protein complexes in this organism as well, 5 suggesting that complex association is a normal property of endogenous tafazzin. In search for differences between the two human isoforms, we discovered that hTAZ-FL was not as tightly bound to the membrane by hydrophobic interaction as hTAZ-⌬5. Although it is likely that hTAZ-⌬5 and hTAZ-FL have different topologies within their protein complexes, more work is required to determine whether this 5 A. Malhotra, M. Ren, and M. Schlame, unpublished data. difference has any functional consequences, such as access to specific substrate pools in human mitochondria, or whether it may explain the observed differences in climbing activities between ⌬TAZϩhTAZ-⌬5 and ⌬TAZϩhTAZ-FL (Fig. 5) .
What Is the Role of Exon 5 in Human Tafazzin?-Exon 5 encodes a peptide of 30 amino acids, which evolved after the hominoid primate lineage branched off the Old World monkey lineage (9) . Translation of exon 5 gives rise to the formation of hTAZ-FL, a specific modification of tafazzin that is present only in humans and apes. Because hTAZ-FL was able to complement tafazzin-deficient Drosophila (Fig. 6) but not tafazzindeficient yeast (11) , it may be functional only in the mitochondria of higher organisms. However, the actual function of hTAZ-FL and the reason that humans express two enzymatically active tafazzins is not known. Recently, a polymorphism was identified in exon 5 (F128S) with an allele frequency of about 4% in African Americans. 6 Because this polymorphism was found in several patients with idiopathic cardiomyopathy, the questions arise whether F128S is a modifier of cardiac disease and whether hTAZ-FL plays a specific role in the development or function of the human heart.
What Determines the Acyl Specificity in CL Remodeling?-Finally, the present data provide further support for the idea that acyl specificity in CL is not caused by substrate specificity of tafazzin (26, 27) . Transgenic expression of human tafazzin in tafazzin-deficient flies generated CL with a Drosophila-type pattern and not CL with a human-type pattern. Thus, it is the host organism rather than the enzyme that determines the molecular species pattern. CL showed exactly the same species pattern regardless of whether flies expressed endogenous dTAZ-A or transgenic dTAZ-A, hTAZ-⌬5, or hTAZ-FL. Also, dTAZ-A, hTAZ-⌬5, and hTAZ-FL induced similar changes in CL upon overexpression in Sf9 insect cells. The data suggest that these tafazzin isoforms behave similarly and, in conjunction with the previous finding that purified tafazzin reacts with a wide range of different substrates (26) , support the notion that tafazzins are relatively nonspecific transacylases. However, CL remodeling clearly acquires acyl specificity in the context of mitochondrial membranes, and a model has been proposed to explain this phenomenon based on energy differences between molecular species (27) . According to this model, the molecular species pattern of CL is determined by the microenvironment of tafazzin, which implies that mislocalizations of tafazzin caused by point mutations (24) may alter the remodeling specificity. Alternatively, mitochondrial enzymes other than tafazzin may participate in CL remodeling, and these enzymes may also have an impact on the acyl specificity of that process (28) .
